The Genomic Atlas of Breast Cancer — the non-coding theme

Update News

  • GABC update 2020.06.15
  • GABC update 2019.03.20
  • GABC online 2018.08.09
  • Data collection 2018.04.09

About Us

  • Steven Xi Chen:
    steven.chen@miami.edu
  • Yunpeng Zhang:
    YXZ1418@med.miami.edu
  • Peng Wang:
    wpgqy@163.com
  • Shangwei Ning:
    ningsw@ems.hrbmu.edu.cn
  • Xia Li:
    lixia@hrbmu.edu.cn

Detail


Chr NA
start NA
end NA
ID NA
miRNA_name hsa-miR-663
methods qRT-PCR,etc.
regulated up
Function Description The exhilarating and fast-growing field of miRNAs and their ver-satilityintargetedtherapyagainstcancer,mayonedaybepracticable.Abnormal expression of miRNAs has been observed in most of thecancertype'srightthroughcancerearlierandlatestages.Thus,miRNAsportray as a very strong target in cancer therapy. Phytological-com-pound mediated therapy displayed a unique ability to modify miRNAslevel implicated in controlling pathobiology of cancer via transcrip-tional, miRNA processing and epigenetic mechanisms. These naturalcompoundsevaluatedbothin-vivoandinclinicaltrialsmightbeusedtotargetdiversesignalingpathwaysthroughspecificmiRNAs.Inaddition,phytological-compounds found to increase the chemo-sensitivity oftraditionaldrugsthroughmodulatingmiRNAs.Thesecompoundsmightbe subjugated for scheming therapeutic approaches in combinationwith traditional remedies to improve cancer therapies and prevention.Thereisanextensivescopeforthedevelopmentofphytochemicalintocommercial drugs to efficaciously prevent and treat cancer
PMID 31982837
year 2020
Title Modification of miRNA Expression through plant extracts and compounds against breast cancer: Mechanism and translational significance.
drug X
circulating X
survival X

CopyRight © University of Miami, USA; Harbin Medical University, China